Product image of Memantine Orion (Memantine Hydrochloride) supplied by GNH India

Memantine Orion

Active Ingredient:
Memantine Hydrochloride
Origin:
EU

Memantine Orion (Memantine Hydrochloride)

Memantine Hydrochloride, the active ingredient in Memantine Orion, is a NMDA receptor antagonist presented as an oral tablet for oral use. It is indicated for the treatment of Alzheimer’s disease in adult patients, helping to reduce excitotoxic neuronal damage associated with disease progression.

GNH India supplies Memantine Orion as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Orion Corporation

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Memantine Orion is an NMDA receptor antagonist used in the management of Alzheimer’s disease, a neurodegenerative disorder affecting cognition and function.

  • Mild‑to‑moderate Alzheimer’s disease: modest improvement in cognition and daily functioning.
  • Moderate‑to‑severe Alzheimer’s disease: may slow functional decline and support independence.
  • Behavioral symptoms in Alzheimer’s disease: can reduce agitation and improve patient comfort.

How It Works

  • Memantine Hydrochloride acts as a non‑competitive antagonist at the NMDA (N‑methyl‑D‑aspartate) receptor. By blocking excessive calcium influx through the NMDA channel, it reduces excitotoxic neuronal injury while preserving normal synaptic transmission, thereby helping to maintain neuronal function in Alzheimer’s disease.

Side Effects

Memantine Orion may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects

  • Dizziness: transient sensation of light‑headedness.
  • Headache: mild to moderate intensity.
  • Constipation: reduced bowel movements.
  • Fatigue: feeling of tiredness.
  • Confusion: temporary disorientation.
  • Hypertension: mild increase in blood pressure.

Serious or Rare Side Effects

  • Seizures: rare occurrence of convulsive episodes.
  • Cardiac arrhythmia: irregular heart rhythm.
  • Severe skin reactions: such as Stevens‑Johnson syndrome.
  • Suicidal thoughts: emergent mood changes requiring immediate attention.

Precautions & Warnings

When prescribing Memantine Orion, clinicians should consider several safety aspects.

  • Renal impairment: adjust dose or monitor closely in patients with reduced kidney function.
  • Hepatic impairment: use with caution in liver disease.
  • Concomitant CNS depressants: monitor for additive sedation.
  • Pregnancy: safety not established; avoid unless benefit outweighs risk.
  • Elderly patients: start at low dose and titrate slowly.
  • Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Avoid Interactions

Memantine Orion can interact with other medicines, requiring attention to avoid adverse outcomes.

Major Interactions (Avoid)

  • Amantadine: combined NMDA antagonism may increase toxicity.
  • Ketamine: additive CNS effects and heightened neurotoxicity risk.
  • Other NMDA antagonists: may potentiate adverse neurological effects.

Moderate Interactions (Monitor Closely)

  • Antihypertensive agents: possible additive blood pressure lowering.
  • Diuretics: monitor electrolytes and renal function.
  • CNS depressants (e.g., benzodiazepines): may enhance sedation and dizziness.

Frequently Asked Questions

Memantine Orion contains memantine hydrochloride, an NMDA receptor antagonist prescribed to treat Alzheimer’s disease. It helps improve or maintain cognitive function and daily living abilities in adults with mild to moderate disease, and may slow functional decline in more advanced stages.

Memantine blocks the NMDA receptor channel in a non‑competitive manner, reducing excessive calcium entry that can cause neuronal injury. By moderating excitotoxicity while preserving normal neurotransmission, it supports neuronal health and function in patients with Alzheimer’s disease.

The appropriate dose of Memantine Orion is determined by the prescribing clinician based on the patient’s condition, renal function, and response to therapy. Dosage regimens are individualized and should follow the prescriber’s instructions.

Safety data for memantine during pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Memantine belongs to the NMDA antagonist class, differing from acetylcholinesterase inhibitors such as donepezil. While both improve cognition, memantine is typically used for moderate to severe disease and has a distinct side‑effect profile, making it a complementary option rather than a direct substitute.

Memantine Orion tablets should be stored at ambient temperature, below 25 °C, in their original packaging to protect from moisture and light. Keep out of reach of children and do not use if the packaging is damaged.

Memantine Orion is taken orally, usually once daily after a meal to improve tolerability. The tablet should be swallowed whole with water and not crushed or chewed unless specifically instructed by a healthcare provider.

Serious adverse events, though rare, include seizures, cardiac arrhythmias, severe skin reactions such as Stevens‑Johnson syndrome, and emergent suicidal thoughts. Patients should seek immediate medical attention if any of these symptoms occur.

Memantine Orion is contraindicated in patients with known hypersensitivity to memantine or any excipients in the formulation. Caution is advised for individuals with severe renal impairment, uncontrolled hypertension, or those taking other NMDA antagonists.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Memantine Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT